Bristol's Glucophage (metformin) antihyperglycemic cost of therapy will be about $365 per year.
Executive Summary
BRISTOL GLUCOPHAGE LAUNCHING AT AVERAGE ANNUAL COST OF OVER $365, Bristol-Myers Squibb said during a May 4 teleconference announcing the launch of Glucophage (metformin) for Type II non-insulin dependent diabetes. The price of Glucophage will range from $296 to $767 per year at the maintenance doses of 1,000 mg to 2,550 mg per day. BMS said that the average patient would pay just over $1 per day.